Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Buy Dishman Pharma; target of Rs 285: Systematix

    • Buy Dishman Pharma; target of Rs 198: Karvy

    • Buy Dishman Pharma; target of Rs 200: Dynamic Levels

    • Buy Dishman Pharma; target of Rs 189: Angel Broking

    • Buy Dishman Pharma; target of Rs 217: Angel Broking

    • Buy Dishman Pharma; target of Rs 177: Angel Broking

    • Buy Dishman Pharma; target of Rs 123: Angel Broking

    • Buy Dishman Pharma, HT Media: Angel Broking

    • Buy Dishman Pharma, TVS Motor advises Systematix Shares

    • Buy CEAT, Dishman Pharmaceuticals: Angel Broking

      Brokerage house Angel Broking is bullish on CEAT, Dishman Pharmaceuticals and has recommended buy rating on both the stocks with a target price of Rs 170 and Rs 132 respectively in its research reports dated August 2, 2013.

    • Buy Dishman Pharma; target of Rs 155: Angel Broking

      Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 155 in its February 11, 2013 research report.

    • Motilal Oswal neutral on Dishman Pharma

      Motilal Oswal has maintained neutral rating on Dishman Pharma with a target of Rs 103, in its August 2, 2012 research report.

    • Buy Dishman Pharma; target of Rs 92: Angel Broking

      Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 92 in its May 15, 2012 research report.

    • Reduce Dishman Pharma; target of Rs 61: KRChoksey

      KRChoksey is bearish on Dishman Pharma and has recommended reduce rating on the stock with a target of Rs 61 in its February 13, 2012 research report.

    • Accumulate Dishman Pharma; target of Rs 64: Dolat Capital

      Dolat Capital is bullish on Dishman Pharma and has recommended accumulate rating on the stock with a target of Rs 64 in its February 10, 2012 research report.

    • Buy Dishman Pharmaceuticals; target Rs 68: Angel Broking

      Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 68 in its November 16, 2011 research report.

    • Hold Dishman Pharma; target Rs 100: KRChoksey

      KRChoksey has maintained hold rating on Dishman Pharmaceuticals (DPL) with a target price of Rs 100 in its July 29, 2011 research report.

    • Buy Dishman Pharma; target of Rs 133: Angel Broking

      Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 133 in its August 1, 2011 research report.

    • Buy Dishman Pharma; target of Rs 133: Angel Broking

      Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 133 in its May 27, 2011 research report.

    • Hold Dishman Pharma; target of Rs 103: KRChoksey

      KRChoksey has recommended hold rating on Dishman Pharma with a target of Rs 103, in its May 27, 2011 research report.

    • Accumulate Dishman Pharma; target of Rs 125: Emkay

      Emkay Global Financial Services is bullish on Dishman Pharmaceuticals & Chemicals and has recommended accumulate rating on the stock with a target of Rs 125 in its April 11, 2011 research report.

    • Which 7 stocks is Emkay bearish on?

      Emkay Global Financial Services has come out with a report on top recommendation.

    • Buy Dishman Pharma; target of Rs 123: Angel Broking

      Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 123 in its February 15, 2011 research report.

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347